 |
|
|
| |
AL-034 (or TQ-A3334), a Selective Toll-like Receptor 7 Agonist for Oral Treatment of Chronic Hepatitis B Virus Infection
|
| |
| |
Reported by Jules Levin'
AASLD, Washington DC, USA, October 20-24 2017
AASLD: Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-56136379, a Novel HBV Capsid Assembly Modulator, in Non-cirrhotic, Treatment-naïve Patients with Chronic Hepatitis B. - (11/01/17)
An De Creus1, Tine Thoné1, Thierry Verbinnen1, Dorien Verstappen1, Christel Van den Eynde1, Tom Vervoort1, Zhengxian Gu2, Qiong Zhou2, Fei Sun2, Ya Sun2, Charles Z. Ding2, Xiquan Zhang3, Ling Yang3, Xin Tian3, Hongjiang Xu3, Frederik Pauwels1, Leonid Beigelman4, John Fry4, Tse-I Lin4
1Janssen Research & Development, Beerse, Belgium; 2WuXi AppTec, Shanghai, China; 3Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Nanjing, China; 4Alios Biopharma, San Francisco, CA, USA
|
| |
|
|
|
|
|
